Meeting
2017 ASCO Annual Meeting
What drives patient outcomes in brain metastases: Number, volume, or biology?
Authors
Rupesh Kotecha
Department of Radiation Oncology, Cleveland Clinic Foundation, Cleveland, OH
Rupesh Kotecha , Jacob A Miller , Samuel T. Chao , Alireza Mohammad Mohammadi , Erin Sennett Murphy , John H. Suh , Gene H. Barnett , Michael A. Vogelbaum , Lilyana Angelov , Manmeet Singh Ahluwalia
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Brain Metastases
Citation
J Clin Oncol 35, 2017 (suppl; abstr 2071)
DOI
10.1200/JCO.2017.35.15_suppl.2071
Abstract #
2071
Poster Bd #
313
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Pretreatment clinical parameters associated with intracranial progression burden following an initial stereotactic radiosurgery course in a multi-institutional brain metastases cohort.
First Author: Christina C Huang
Poster
2023 ASCO Annual Meeting
Brain metastasis burden and management in small cell lung cancer: An analysis of 8705 patients.
First Author: Karolina Gaebe
Poster
2021 ASCO Annual Meeting
Predictors of overall survival (OS) in patients (pts) with melanoma brain metastasis (MBM) in the modern era.
First Author: Merve Hasanov
Poster
2021 ASCO Annual Meeting
Patterns of survival in NSCLC with de novo brain metastasis: SRS, WBRT, and no radiotherapy cohorts.
First Author: Diana Saravia